-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AZvP47yxurJTAZK9UbiZTbwVqeYY71SgQdBHsvFTozf8+2rpoa3JhUATA85zP6PX l6mP6UHkJu1UKi99dh793Q== 0000890163-07-000637.txt : 20071022 0000890163-07-000637.hdr.sgml : 20071022 20071022171530 ACCESSION NUMBER: 0000890163-07-000637 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071010 FILED AS OF DATE: 20071022 DATE AS OF CHANGE: 20071022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Newsome David A. CENTRAL INDEX KEY: 0001415360 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 071183724 BUSINESS ADDRESS: BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 3930 VARSITY DRIVE STREET 2: C/O PIPEX PHARMACEUTICALS, INC. CITY: ANN ARBOR STATE: MI ZIP: 48108 3 1 s11-7828_ex.xml X0202 3 2007-10-10 0 0000894158 PIPEX PHARMACEUTICALS, INC. PP 0001415360 Newsome David A. 3930 VARSITY DRIVE C/O PIPEX PHARMACEUTICALS, INC. ANN ARBOR MI 48108 0 1 0 0 Chief Scientific Officer Common Stock 0 D Stock Options Common Stock D Dr. Newsome does not currently own any stock options to purchase shares of the Issuer's common stock. However, pursuant to an employment agreement between the Issuer and Dr. Newsome, the Issuer will grant 150,000 stock options to Dr. Newsome that are exercisable into 150,000 shares of the Issuer's common stock exercisable at the fair market value of the Issuer's common stock on the date of the grant. The Issuer will issue these options immediately following the Issuer's meeting of stockholders scheduled to be held on November 2, 2007 assuming that the stockholders approve the Issuer's 2007 Stock Incentive Plan. /s/ Dr. David A. Newsome 2007-10-19 -----END PRIVACY-ENHANCED MESSAGE-----